STOCK TITAN

Theravance Biopharma, Inc. (TBPH) Free Cash Flow by Year

TBPH

Theravance Biopharma, Inc. generated $238.5M in free cash flow in fiscal year 2025. This represents an increase of 2109.8% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Theravance Biopharma, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow $238.5M
YoY +2109.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TBPH Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Free Cash Flow$238.5M+2109.8%-$11.9M+59.8%-$29.5M+84.3%-$187.6M+11.2%-$211.3M+17.8%-$257.0M-6.5%-$241.4M-101.0%-$120.1M+41.0%-$203.5M-101.2%-$101.1M+41.0%-$171.5M+3.8%-$178.3M-44.1%-$123.7M-1.6%-$121.7M

TBPH Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-KQ1'2410-KQ4'2310-KQ3'2310-K
Free Cash FlowN/AN/A-$6.1M-456.0%-$6.5M-24.9%N/AN/A-$1.1M+28.7%-$5.2M-107.9%-$4.5M+66.5%-$1.1M+90.8%-$1.5M+98.8%-$2.5M+88.7%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Theravance Biopharma, Inc. financials

Frequently Asked Questions

What was Theravance Biopharma, Inc.'s free cash flow in fiscal year 2025?

Theravance Biopharma, Inc. generated $238.5M in free cash flow in fiscal year 2025.

How fast is Theravance Biopharma, Inc.'s free cash flow growing?

Theravance Biopharma, Inc. (TBPH) free cash flow rose by 2109.8% year over year, from -$11.9M to $238.5M in fiscal year 2025.

How has Theravance Biopharma, Inc.'s free cash flow changed over the years?

Across the 14 fiscal years this page covers, Theravance Biopharma, Inc. (TBPH) free cash flow went from -$121.7M in fiscal year 2012 to $238.5M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Theravance Biopharma, Inc. (TBPH) reported on that line in every period on record.